Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Instruments Plc LSE:OXIG London Ordinary Share GB0006650450 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 1,218.00p 1,206.00p 1,216.00p - - - 0 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic & Electrical Equipment 333.6 35.5 52.4 23.2 700.65

Oxford Instruments Share Discussion Threads

Showing 726 to 749 of 775 messages
Chat Pages: 31  30  29  28  27  26  25  24  23  22  21  20  Older
DateSubjectAuthorDiscuss
20/11/2018
09:07
Looks like IC has spread the seeds of doom...currently down £1.50 on the month. Might be time to add a few ..
wad collector
14/11/2018
20:38
If you value it as a manufacturer , the 3.8p dividend is pretty trivial , though 27p EPS bit more impressive. Debt down is good.Haven't seen IC yet , but the half yearly results seem reasonable , though comparison with last yr has to be seen in the light of poor performance that yr. Yesterday; Financial Highlights: -- Orders up 10.3% to GBP162.9m (2017: GBP147.7m), an increase of 12.0% at constant currency -- Order book of GBP177.9m (31 March 2018: GBP153.0m, restated for IFRS 15) up 16.3% (12.5% at constant currency) -- The Group has adopted IFRS 15 'Revenue from Contracts with Customers' and IFRS 16 'Leases'. The impact is to increase revenue by GBP5.1m -- Reported revenue increased by 11.3% to GBP147.0m (12.6% at constant currency) -- Adjusted operating profit from continuing operations up 11.7% to GBP21.0m (16.0% at constant currency) with margin rising to 14.3% -- Adjusted profit before tax from continuing operations up 21.5% to GBP19.8m -- Reported profit before tax down 8.7% to GBP11.6m due to mark-to-market movement on currency derivatives -- Strong cash conversion of 91.0% contributes to reduction in net debt to GBP12.5m -- Interim dividend increased by 2.7% to 3.8p Operational Highlights: -- Continued progress with the implementation of our Horizon strategy - Good underlying order and revenue growth - Continued focus on innovation and R&D
wad collector
14/11/2018
12:51
IC appears to be saying the rating is too high.
essentialinvestor
29/10/2018
10:56
The Chairmans AGM statement was quite positive ..so hope it follows through.
meijiman
29/10/2018
09:57
Wow this board is humming! Half yearly results out in 2 weeks ; 13 November. I see the Broker consensus is still around EPS 58p for the year FWIW.
wad collector
03/7/2018
10:27
Didn't get around to it. sorry wad. Had to sell up to buy more OXB. GLA
volsung
15/6/2018
14:58
Good to see you on board volsung ; I look forward to some pithy postings.
wad collector
15/6/2018
08:43
Like the look of Oxig. In with a small tranche today
volsung
14/6/2018
10:06
Up sharply today , I see an IC article yesterday which suggests HOLD Around this time last year, Oxford Instruments (OXIG) announced its 'Horizon' growth strategy. It's still early days in terms of implementation, but a 5 per cent increase in orders to £313m suggests progress has been made, while continued spend on R&D – £24.8m, or 8.4 per cent of sales – demonstrates that the group is determined to expand and optimise the technologies within its proprietary offering (profit and margin growth in the service and healthcare division was driven by services relating to in-house products). Oxford Instruments reversed last year's reported losses, but two factors flattered this result. First was the impact of foreign exchange. Strip out translation effects and adjusted pre-tax profit improved by 0.6 per cent. Full-year returns were also helped along by £80m garnered from the sale of the industrial analysis business, which along with an 18.5 per cent increase in operating cash flows (before working capital movements), enabled the group to cut its net debt from £109m in FY2017 to £19.7m at the period end. An intensified focus on the nanotechnology business – part of the wider materials and characterisation division – contributed to an 11.7 per cent rise in sales to £118m, which helped to compensate for a 10.5 per cent revenue decline in the research and discovery business, resulting from longer lead times on some orders. Prior to this announcement, analysts at JPMorgan expected pre-tax profits of £42m during the year to March 2019, giving EPS of 56.4p, up from £41m and 55p in FY2018. OXFORD INSTRUMENTS (OXIG) ORD PRICE: 983p MARKET VALUE: £564m TOUCH: 974-983p 12-MONTH HIGH: 1,174p LOW: 676p DIVIDEND YIELD: 1.4% PE RATIO: 29 NET ASSET VALUE: 312p* NET DEBT: 11% Year to 31 Mar Turnover (£m) Pre-tax profit (£m) Earnings per share (p) Dividend per share (p) 2014 360 24.0 32.1 12.4 2015 380 -9.6 -10.9 13.0 2016 320 9.7 12.2 13.0 2017 300 -26.2 -44.7 13.0 2018 297 34.2 34.3 13.3 % change -1 - - +2 Ex-div: 13 Sep Payment: 19 Oct *Includes intangible assets of £159m, or 276p a share IC View It's too early to say whether the Horizon growth strategy is having a discernible effect on trading, although the substantive deleveraging played well with analysts. The shares are trading in line with historic earnings metrics relative to peers, so there's still no obvious value argument on offer. Hold. Last IC View: Hold, 961p, 15 Nov 2017
wad collector
12/6/2018
12:58
Yes; full year results much more positive in both results and outlook. Suspect this will create a few broker notes and a significant further rise.
wad collector
12/6/2018
10:33
Reads well..underlying confidence in prospects.
meijiman
12/4/2018
16:55
Might be a good exit point. My recent trades have gone badly so will hold out longer here. I want £18 again!
wad collector
12/4/2018
11:46
I've decided to take my profit, luck to anyone holding.
essentialinvestor
12/4/2018
11:34
Bloody lovely )).
essentialinvestor
12/4/2018
10:45
Tipped in motley fool yesterday,presumably part of the reason for today's surge. hxxps://www.aol.co.uk/news/2018/04/11/two-growth-monsters-i-believe-could-jump-50-or-more/
wad collector
11/4/2018
16:40
Don't expect they will ; they will await a down day. OXIG has always struck me as an engineering company that would like to be valued as an R&D company. It seems overvalued as the former but undervalued as the latter. Here's hoping....
wad collector
11/4/2018
14:51
Update as I hoped for, net debt comment very welcome indeed. Some poster told me to.. get a grip.. here a few weeks ago, any comment from that person today?.
essentialinvestor
11/4/2018
09:35
Update is in line ; hopefully will give the share price some tailwind.
wad collector
10/4/2018
12:49
Very pleased with the share price recent recovery.
essentialinvestor
03/4/2018
14:34
Nicely ahead atm, although given the volatility that change in seconds.
essentialinvestor
15/3/2018
19:52
EI Yes, better day. Well done:-) Yes 20/20 hindsight, I should have held Skg. Never saw a bid coming and, having discussed them with a fellow investor, I did see negatives. I never intended to be a long term holder.
redartbmud
15/3/2018
16:38
Better day.
essentialinvestor
13/3/2018
13:10
You may well be right. OXIG has previously traded from near £6, to over £10 within a few months. It can be highly volatile, however accept it's higher risk and there may be unpleasant news to come. Soon find out.
essentialinvestor
13/3/2018
12:30
Meij, the SKG comment was for red, as we both had some SKG last year. My current OXIG is 2100 shares, it's not a bet the farm position.
essentialinvestor
Chat Pages: 31  30  29  28  27  26  25  24  23  22  21  20  Older
Your Recent History
LSE
OXIG
Oxford Ins..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190617 06:50:58